A coalition of 100 investors announced plans to build a "Chinese-controlled economic zone" populated by skyscrapers and luxury residences. Their new city will be in Kenya, but the goal is to "match the glamour of Dubai." What would motivate investors to go to the trouble of building a massive new city in a country other than their own? It's pretty simple, actually.
C Spire customers had to wait months after the initial launch to get the Galaxy S 4, but they won't have to be nearly so patient with the Galaxy S5. The southern US carrier has revealed that it will be carrying Samsung's Android flagship in May, just...
Tetris is turning 30 (yes, thirty!) in June, so some folks threw it one epic pre-birthday party at Philly Tech Week's kickoff event this April 5th. What'd they do, you ask? They used the 29-story Cira Centre building as a screen to play an enormous...
In addition to completely freaking us out
     |
Whether you're looking for new poses to learn or just getting started with yoga, these are the best yoga apps for iPad
What are the best iPad apps for practicing yoga on the go or AirPlaying programs to your TV? Yoga is a great form of exercise to help you lose weight, reduce stress, and enhance flexibility. One of the best things about yoga is that you can do it virtually anywhere. That's especially true with the iPad, whether you want to practice poses or complete workouts, and whether you're a yoga master or just getting started, there's something for everyone. The App Store has many yoga app options, but which ones are the very best?
Pocket Yoga is filled with all kinds of yoga poses for you to practice and learn. You can either view them and the purpose of each on your own or perform classes. As you complete workouts you will earn in-app karma points that you can use to unlock new environments.
If you want a challenge and an app you can learn and excel with, check out Pocket Yoga.
Yoga Studio comes with HD video classes built right in and almost 300 poses. You can also create your own classes if you'd like and save them for later. Use the scheduling tool to make sure you never miss a yoga session. From beginners to mastering harder techniques and poses, Yoga Studio does a great job of spanning both areas.
If you want the best videos and tutorials, check out Yoga Studio.
Yoga.com Studio breaks out yoga in a way that real people who may not have much contact with it can understand. The main menu is presented like a beautiful magazine cover that is yours to explore. There are over 300 poses and video classes to choose from. You can also specify what goals you want to achieve and Yoga.com studio presents you with classes that help. For example, if you're trying to eliminate back pain, there are sessions available specifically for that.
If you want to target specific areas or eliminate focused kinds of pain, look no further than Yoga.com Studio.
The main focus on Daily Yoga is to help people wanting to lose weight or eliminate pain. Daily Yoga features both HD videos that show detailed steps of poses as well as companion music. There are over 40 yoga sessions available and 300 poses. You can subscribe via in-app purchase for even more content as well.
If you want to get into a regular routine in order to lose weight or relieve stress and pain, Daily Yoga is a safe bet.
For those that want to just start a yoga workout with zero effort, there's Simply Yoga. Instead of giving you lists of poses and classes to choose from, just select the duration and a few other things and start your workout. That's it. No more, no less. The design isn't so great but the videos are high quality and explain poses very well.
For straight forward yoga classes, nothing else — check out Simply Yoga.
If you do yoga as a form of exercise or stress relief, what iPad apps have you found helpful? Let me know in the comments!
| |
Find My Friends has been updated with a new design for iOS 7. This is the last of Apple's major apps to receive an iOS 7 redesign.
| |
There are two types of people in this world: those who like the convenience of autofill, and those who don't think a browser should double as a PA. For the former group, Google's updating its mobile Chrome apps today, and autophilics will be pleased to hear the feature is being added to iOS, with form data from other devices synced up for immediate use. Chrome for Android received autofill abilities earlier this year, but today's update should "further streamline online forms" to save you a little bit more time. Retailers need to adopt this "faster checkout flow" on their end (Betabrand is in from the get-go), but with the holidays coming up, we're sure several sites will want to make those last-minute purchases as painless as possible. Now, we're off to order some Catan socks.
![[ Back to EurekAlert! ]](https://www.eurekalert.org/images/back2e.gif){kind=small}
PUBLIC RELEASE DATE: 12-Nov-2013
ShareContact: Gregory Poon
gpoon@wsu.edu
509-335-8341
Washington State University
PULLMAN, Wash. A class of drugs used to treat parasitic infections such as malaria may also be useful in treating cancers and immune-related diseases, a new WSU-led study has found.
Researchers discovered that simple modifications to the drug furamidine have a major impact on its ability to affect specific human proteins involved in the on-off switches of certain genes.
"This was rather unexpected, given how relatively simple the molecules are that we modified and how difficult it has been to affect these proteins," said Gregory Poon, pharmaceutical scientist at Washington State University.
The proteins known as transcription factors regulate the expression of genes in a highly coordinated and intricate manner, making them attractive targets for therapeutic drugs. But it has proven difficult to design drugs to affect them, Poon said.
"For this reason, they have been called undruggable," he said. "Recently, however, scientists have been making headway in targeting these transcription factors with drugs, and now our results suggest this class of drugs can be a useful addition to the arsenal."
Furamidine belongs to a family of drugs known as heterocyclic dications. The drug has a long history of use in serious parasitic diseases such as malaria, African sleeping sickness and PCP, a common infection in HIV/AIDS.
"There is tremendous knowledge and experience with using furamidine and related drugs in humans, so these drugs have an important advantage over other classes of drugs that are relatively behind in clinical experience," Poon said.
Poon collaborated with researchers at Georgia State University. The team found that derivatives of furamidine can target a specific transcription factor known as PU.1.
PU.1 is a major factor in development and function of the human immune system, and it plays important roles in diseases such as some leukemias, multiple sclerosis and diabetes. PU.1 is also a member of a large family of related transcription factors, known as ETS, that is involved in a broader range of cancers and other diseases.
"I am fortunate to be working with some of the best people in this area," Poon said, referring to his collaborators, Dave Boykin and David Wilson of Georgia State University. "The challenge now is to fine-tune this class of drugs to make them as specific as possible to other ETS-family transcription factors as well."
###
Their research is supported by the WSU College of Pharmacy and by the National Institutes of Health at Georgia State University.
[
| E-mail
Share
]
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
PUBLIC RELEASE DATE: 12-Nov-2013
ShareContact: Gregory Poon
gpoon@wsu.edu
509-335-8341
Washington State University
PULLMAN, Wash. A class of drugs used to treat parasitic infections such as malaria may also be useful in treating cancers and immune-related diseases, a new WSU-led study has found.
Researchers discovered that simple modifications to the drug furamidine have a major impact on its ability to affect specific human proteins involved in the on-off switches of certain genes.
"This was rather unexpected, given how relatively simple the molecules are that we modified and how difficult it has been to affect these proteins," said Gregory Poon, pharmaceutical scientist at Washington State University.
The proteins known as transcription factors regulate the expression of genes in a highly coordinated and intricate manner, making them attractive targets for therapeutic drugs. But it has proven difficult to design drugs to affect them, Poon said.
"For this reason, they have been called undruggable," he said. "Recently, however, scientists have been making headway in targeting these transcription factors with drugs, and now our results suggest this class of drugs can be a useful addition to the arsenal."
Furamidine belongs to a family of drugs known as heterocyclic dications. The drug has a long history of use in serious parasitic diseases such as malaria, African sleeping sickness and PCP, a common infection in HIV/AIDS.
"There is tremendous knowledge and experience with using furamidine and related drugs in humans, so these drugs have an important advantage over other classes of drugs that are relatively behind in clinical experience," Poon said.
Poon collaborated with researchers at Georgia State University. The team found that derivatives of furamidine can target a specific transcription factor known as PU.1.
PU.1 is a major factor in development and function of the human immune system, and it plays important roles in diseases such as some leukemias, multiple sclerosis and diabetes. PU.1 is also a member of a large family of related transcription factors, known as ETS, that is involved in a broader range of cancers and other diseases.
"I am fortunate to be working with some of the best people in this area," Poon said, referring to his collaborators, Dave Boykin and David Wilson of Georgia State University. "The challenge now is to fine-tune this class of drugs to make them as specific as possible to other ETS-family transcription factors as well."
###
Their research is supported by the WSU College of Pharmacy and by the National Institutes of Health at Georgia State University.
[
| E-mail
Share
]
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Recent Comments